Back
Celldex Therapeutics Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Buy
58
CLDX
Celldex Therapeutics
Last Price:
41.15
Seasonality Move:
-0.32%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- The current trend is moderately bullish and CLDX is experiencing selling pressure, which indicates risk of future bearish movement.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.23 | Sell |
| 20-day SMA: | 40.76 | Buy |
| 50-day SMA: | 38.36 | Buy |
| 200-day SMA: | 38.66 | Buy |
| 8-day EMA: | 42.1 | Sell |
| 20-day EMA: | 40.81 | Buy |
| 50-day EMA: | 39 | Buy |
| 200-day EMA: | 37.5 | Buy |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.5 | Buy |
| Relative Strength Index (14 RSI): | 56.29 | Buy |
| Chaikin Money Flow: | -545523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.85 - 43.05) | Buy |
| Bollinger Bands (100): | (34.5 - 40.9) | Buy |
Celldex Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 41.85 while CLDX 8-day simple moving average is 42.23, which is a Sell signal.
- The stock price of CLDX is 41.85 while Celldex Therapeutics 20-day SMA is 40.76, which makes it a Buy.
- Celldex Therapeutics 50-day simple moving average is 38.36 while CLDX share price is 41.85, making it a Buy technically.
- CLDX stock price is 41.85 and Celldex Therapeutics 200-day simple moving average is 38.66, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Buy
The current Celldex Therapeutics [CLDX] share price is $41.85. The Score for CLDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.77B
Price in USD:
41.85
Share Volume:
933.2K
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 41.85 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is not overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 41.85 while CLDX 8-day exponential moving average is 42.10, which is a Sell signal.
- The stock price of CLDX is 41.85 while Celldex Therapeutics 20-day EMA is 40.81, which makes it a Buy.
- Celldex Therapeutics 50-day exponential moving average is 39.00 while CLDX share price is 41.85, making it a Buy technically.
- CLDX stock price is 41.85 and Celldex Therapeutics 200-day simple moving average is 37.50, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is 1.5, suggesting Celldex Therapeutics is a Buy
- Celldex Therapeutics Relative Strength Index (RSI) is 56.29, which suggest Celldex Therapeutics is overbought
- The Bollinger Bands (25) for Celldex Therapeutics is (35.85 - 43.05), which suggest Celldex Therapeutics is a Buy
- The Bollinger Bands (100) for Celldex Therapeutics is (34.5 - 40.9), which suggest Celldex Therapeutics is a Buy
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.